Best-effort research profile: this record has not passed full two-source scientific verification. Descriptive fields, research protocols, storage/handling notes, and interaction guidance below are shown with their evidence labels, but calculator presets and exact dosing math remain hidden until the record is verified or reaches Community-Supported status.
Quick Facts
Reference Sizes
100 g, 500 g
Storage
No approved consumer storage standard exists for this presentation; follow the lot-specific COA and validated stability data
Solubility
Form, salt, and formulation dependent; verify the lot-specific COA
Best-Effort Research Profile
Rhodiola rosea is an adaptogenic herb studied for stress resilience and cognitive performance under fatigue. A randomized, controlled clinical trial demonstrated statistically significant improvement in total mental performance and reduced overall mental fatigue, including gains in associative thinking, short-term memory, calculation, concentration, and speed of audio-visual perception. An open-label clinical trial also studied Rhodiola rosea in subjects with prolonged or chronic fatigue symptoms. It is classified among a small group of well-studied plant adaptogens (alongside Bacopa monnieri) in the scientific literature addressing chronic stress and lifestyle-related disease.
Source review pending. This descriptive profile is shown from the available source material as a best-effort educational reference. It has not passed the full verification bar and is not a dosing instruction, medical claim, or treatment recommendation.
Research Profile
Half-Life
Not well characterized as a single human PK figure for the whole-herb extract
Onset
RCT effects on mental performance/fatigue typically assessed within weeks
Administration Routes (Research)
Oral
Reported Research Effects
Improved total mental performance and reduced mental fatigue (RCT)
Studied for chronic/prolonged fatigue symptoms (open-label trial)
Classified as an adaptogen supporting stress resilience
Reported Research Side Effects
Human safety, pharmacokinetics, and interaction data are incomplete
Data source: Primary literature, regulator records, trial registries, and identity-specific evidence search
Reflects preclinical/research literature context only. Not a medical claim, dosing instruction, or treatment recommendation.
Route-Specific Research Protocols
Amounts and schedules are separated by administration route. Evidence badges distinguish labels, human studies, preclinical work, community reports, and evidence gaps.
Label / guidelineHuman studyCommunity onlyPreclinical onlyNot established
OralHuman study only
200-400 mg/day of a standardized extract
Frequency / timing
Morning or divided
Duration / setting
4-12 weeks
Technique
Oral
Evidence
Human study protocol
Context: human stress and fatigue trials
Formulation: Oral-mucosal formulations are not dose-equivalent to injectable or topical formulations.
Route safety: Research-study protocol only; it is not an approved or individualized instruction and should not be extrapolated to another route.
Do not convert an amount between routes. Bioavailability, formulation, sterility, monitoring, and clinical context differ by route. Research-use context only; independently verify every cited source.
Research Notes
Extract identity and rosavin/salidroside standardization matter; results are mixed and product-specific.
Supplementary research context only. Not medical advice or a treatment recommendation.
Found a relevant Reddit or forum thread about this compound? Suggest it below. Every suggestion is reviewed by an editor before it appears -- nothing is published automatically.
Research Use Only. All content is for educational and research reference only. Not medical advice, a treatment recommendation, or guidance on human use. Compounds are not FDA-approved drugs unless specifically noted.